Loading clinical trials...
Loading clinical trials...
Multicenter Randomized Trial Evaluating FOLFIRI Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment of Metastatic Colorectal Cancer.
Conditions
Interventions
5-FU
folinic acid
+3 more
Locations
1
Germany
University of Munich - Klinikum Grosshadern
Munich, Germany
Start Date
January 1, 2007
Primary Completion Date
April 1, 2014
Completion Date
December 1, 2016
Last Updated
March 14, 2014
NCT07213804
NCT04704661
NCT06696768
NCT05489211
NCT04657068
NCT06625775
Lead Sponsor
PD Dr. med. Volker Heinemann
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions